Six Medications Seniors Should Review With Their Doctors

Benzodiazepines account for the most fatalities among these medication classes in recent U.S. data through overdoses and respiratory failure. Many older adults continue to receive prescriptions for drugs flagged on the American Geriatrics Society’s Beers Criteria, even as safer options exist. Kidney and liver function decline with age, altering how the body processes medications and raising the chance of adverse effects. Caregivers and patients alike benefit from periodic reviews that weigh current evidence against individual health profiles.

Why Aging Changes Medication Safety

Body composition shifts as people grow older, with increased fat stores and reduced muscle mass affecting drug distribution. Liver and kidney efficiency drops, slowing clearance of many compounds and extending their presence in the system. Brain chemistry also evolves, heightening sensitivity to sedatives and agents that influence cognition. These physiological changes turn once-routine prescriptions into higher-stakes decisions for adults in their seventies and beyond.

Specialists often prescribe in isolation, and communication gaps between providers compound the issue. Outdated prescribing habits persist when newer guidelines have not fully reached every practice. The result leaves seniors exposed to cumulative risks that younger patients rarely encounter at the same intensity.

Benzodiazepines and Z-Drugs

Medications such as Valium, Xanax, Ativan, Ambien, Lunesta, and Sonata target anxiety or insomnia yet frequently produce daytime drowsiness, dizziness, and impaired balance. Falls and fractures rise sharply in this age group, sometimes leading to emergency care or extended hospital stays. Long-term use correlates with memory issues and, in some studies, accelerated cognitive decline.

The Food and Drug Administration has issued consumer warnings about complex sleep behaviors linked to Z-drugs, including sleepwalking and driving while not fully awake. Dependence can develop, prompting dose increases that further elevate danger. Non-drug approaches such as cognitive behavioral therapy for insomnia or improved sleep routines often deliver comparable relief with fewer side effects.

Anticholinergics, NSAIDs, Antipsychotics, and Digoxin

Drugs including Benadryl, Elavil, and Detrol block acetylcholine and have been tied to confusion, constipation, blurred vision, and elevated dementia risk with prolonged exposure. Many seniors unknowingly combine several anticholinergic agents from prescriptions and over-the-counter sources, amplifying the concern.

NSAIDs like ibuprofen and naproxen ease pain and inflammation but raise chances of gastrointestinal bleeding, kidney strain, and cardiovascular complications, especially when paired with common diuretics or blood-pressure medicines. Antipsychotics such as Seroquel, Risperdal, and Haldol carry a Food and Drug Administration black-box warning for use in dementia-related agitation because of increased mortality from heart failure, sudden cardiac events, and infections. Digoxin remains an option for certain heart conditions yet demands precise dosing; age-related kidney changes narrow its safety margin and heighten toxicity risks that include nausea, vision disturbances, and dangerous heart rhythms.

Practical Steps for Patients and Families

Regular medication reconciliation with a physician or pharmacist forms the most direct safeguard. Bring a complete list of prescriptions, over-the-counter products, and supplements to each appointment and ask specifically about Beers Criteria alternatives. The American Geriatrics Society’s 2025 guidance on substitute treatments offers a structured reference for many of these drug classes.

Non-pharmacologic options deserve equal consideration: physical therapy for pain, environmental adjustments for sleep or behavior, and music or routine changes for agitation. These approaches require more initial effort yet preserve independence and reduce adverse-event exposure over time. Stakeholders including primary-care teams, geriatric specialists, and family caregivers share responsibility for keeping regimens current with evolving safety data.

Looking Ahead

Medical knowledge advances, and what counted as standard care two decades ago may no longer represent the best balance of benefit and risk. Seniors and their support networks who treat medication lists as living documents rather than fixed routines position themselves for better long-term outcomes. A single conversation with a trusted clinician can surface options that better align with today’s evidence and an individual’s changing physiology.